Mayo Clinic researchers identify methylated DNA markers -- noninvasive cancer screen
2015-04-21
(Press-News.org) PHILADELPHIA -- A team of Mayo Clinic researchers has succeeded in identifying the source of cancer in patients' gastrointestinal tracts by analyzing DNA markers from tumors. The results open the possibility that doctors could one day be able to screen for cancer anywhere in the body with a noninvasive blood test or stool sample. Such tests, if they prove practical and feasible, could mean greater convenience for patients and saved lives through earlier diagnosis of cancer, especially rare and often lethal diseases such as pancreatic cancer or lung cancer.
The researchers' findings will be presented on April 21 in a poster presentation at the AACR Annual Meeting 2015 in Philadelphia by John Kisiel, M.D., a gastroenterologist at Mayo Clinic.
"What's exciting about our discovery is that it allows us to stop thinking about screening organs and start thinking about screening people," says Dr. Kisiel. "As far as we are aware, this is the first series of experiments that has ever shown this concept." He and his colleagues studied cancer-free patients as well as patients with cancers of the colon or pancreas. By collecting and identifying methylated DNA in a blood test, they were able to identify the presence and origin of the cancerous cells with about 80 percent accuracy. "We think, based on the data we have, that a blood test could work in the future," Dr. Kisiel says.
Researchers double-checked their results by examining methylated DNA in tissue samples, identifying the origin of tumors with greater than 90 percent accuracy. "Our work in tissue shows that we have fairly high precision," says Dr. Kisiel, "but you can't do a screening test in tissue, because you can't biopsy all these tissues at once as part of a screening test. That would not be practical."
The organ-by-organ search for cancer is precisely what Dr. Kisiel and colleagues hope to make unnecessary. While biopsies of organs have saved lives from common malignancies such as breast or prostate cancer, "we can't screen for the less common cancers because the risk of false-positive diagnoses is too high," says Dr. Kisiel. Doctors would unnecessarily worry patients and spend too much time and expense chasing cancers that may not exist. As a result, he says, "a cancer like pancreatic cancer, although it's almost uniformly lethal, is not screened for at all in the general population, mainly because it's rare."
Finding and correctly identifying distinctive methylated DNA from the cancers in a blood or stool sample may change all that. "DNA methylation may be a way to fingerprint not only the tissues themselves, but also the different types of cancer that might arise in those tissues," Dr. Kisiel says.
"We hope that in the future patients might be able to submit a blood specimen and then we can analyze that blood specimen for the presence and absence of cancer markers. And if they are present we hope to be able to determine the anatomic location of the tumor, or the organ from which it originates," he says.
Dr. Kisiel's research applied specifically to the gastrointestinal tract. "We've not yet tested this concept in cancers throughout the entire body, but that is the next step," he says.
Under the best of circumstances, comprehensive cancer screening by blood or stool sample won't be ready any time soon. "Patients shouldn't be waiting for this to come to their physician's office," says Dr. Kisiel. "They should be working with their doctors to get screening tests that are currently available."
INFORMATION:
MEDIA CONTACT: Joe Dangor, Mayo Clinic Public Affairs, 507-284-5005,newsbureau@mayo.edu
MEDIA ALERT: Video and audio area available for download on the Mayo Clinic News Network.
About Mayo Clinic Cancer Center
As a leading institution funded by the National Cancer Institute, Mayo Clinic Cancer Center conducts basic, clinical and population science research, translating discoveries into improved methods for prevention, diagnosis, prognosis and therapy. For information on cancer clinical trials, call 1-855-776-0015 (toll-free).
About Mayo Clinic
Mayo Clinic is a nonprofit organization committed to medical research and education, and providing expert, whole-person care to everyone who needs healing. For more information, visit http://mayocl.in/1ohJTMS, or http://newsnetwork.mayoclinic.org/.
ELSE PRESS RELEASES FROM THIS DATE:
2015-04-21
BUFFALO, N.Y. -- A new study by two researchers in the University at Buffalo School of Social Work has shown that parents who chronically neglect their children contribute to the likelihood that they will develop aggressive and delinquent tendencies later in adolescence, and the one factor that links neglect with those behaviors appears to be poor social skills.
While child neglect can include many different aspects, the study examined two: failure to provide for a child's basic needs and a lack of adequate supervision.
Failure to provide, which includes not meeting ...
2015-04-21
TORONTO, April 21, 2015--The vast majority of surgeons continue to recommend that women 40 years old or older with an average risk for breast cancer be screened annually for the disease, despite a 2009
U.S. Preventive Services Task Force (USPSTF) recommendation that such women be screened biennially beginning at 50 years old and continuing through age 74.
A team of researchers studying the efficacy of policy recommendations on practicing surgeons found that 88% of breast surgeons and 82% of general surgeons continue to recommend annual mammography for women with an ...
2015-04-21
PHILADELPHIA - Liver cancer is often lethal in humans because it is diagnosed in late stages, but new work in animal models has identified a potential diagnostic biomarker of the disease and a potential way to reverse the damage done. The study will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2015 in Philadelphia.
Ying Fu, PhD, of Georgetown Lombardi Comprehensive Cancer Center explains this new work:
"Hepatocellular carcinoma, the most common form of liver cancer, remains the third leading cause of cancer-related deaths worldwide ...
2015-04-21
The body's immune system may be the keeper of a healthy gut microbiota, report University of Chicago scientists on April 21 in the journal Immunity. They found that a single binding protein on white blood cells could affect whether or not mice produced a balanced gut microbiota. Without the protein, harmful bacteria were more easily able to cause infection. Why this happens is unclear, but it may be that the immune system has a way to sense the presence of invading intestinal bacteria.
"Our study reveals how our body's immune system shapes the gut microbiota to naturally ...
2015-04-21
An immune cell protein, ID2, is critical for the maintenance of healthy gut microbiota and helps these good bacteria fight off harmful bacteria, report scientists from the University of Chicago. The study, published in Immunity on April 21, suggests that novel therapeutics or microbiota transplantation could be used to promote the development of good gut microbiota to indirectly kill harmful bacteria for patients with recurrent gut infection.
"Our study reveals how our body's immune system shapes the gut microbiota to naturally limit infections," says senior author Yang-Xin ...
2015-04-21
The immune system is designed to protect us from disease. But what if it was malfunctioning? Would it make a disease worse? That appears to be the case with Rett syndrome, a neurodevelopmental disorder, and possibly in other neurological disorders as well, new research from the University of Virginia School of Medicine has found.
UVA's discovery suggests that immune cells bearing a mutation in the Rett gene, MeCP2, cannot perform their normal function and are instead amplifying the disease. By identifying a new role of the immune system in the disorder, through cells ...
2015-04-21
In order to sing or speak, around one hundred different muscles in our chest, neck, jaw, tongue, and lips must work together to produce sound. Beckman researchers investigate how all these mechanisms effortlessly work together--and how they change over time.
"The fact that we can produce all sorts of sounds and we can sing is just amazing to me," said Aaron Johnson, affiliate faculty member in the Bioimaging Science and Technology Group at the Beckman Institute and assistant professor in speech and hearing science at Illinois. "Sounds are produced by the vibrations of ...
2015-04-21
COLUMBUS, Ohio - It's estimated that six out of 1,000 children worldwide are affected by autism spectrum disorder (ASD), and 50 percent demonstrate serious and disruptive behavior, including tantrums, aggression, self-injury and noncompliance.
For children with ASD, serious disruptive behavior interrupts daily functioning and social skills development, limits their ability to benefit from education and speech therapy, can increase social isolation and intensify caregiver stress.
Luc Lecavalier and his team of researchers from The Ohio State University Wexner Medical ...
2015-04-21
In a small study that included seven children and teens with Wiskott-Aldrich syndrome, a rare immunodeficiency disorder, use of gene therapy resulted in clinical improvement in infectious complications, severe eczema, and symptoms of autoimmunity, according to a study in the April 21 issue of JAMA, a theme issue on child health.
Wiskott-Aldrich syndrome (WAS) is caused by loss-of-function mutations in the WAS gene. The condition is characterized by thrombocytopenia (low platelet count), eczema, and recurring infections. In the absence of definitive treatment, patients ...
2015-04-21
In a study that included approximately 95,000 children with older siblings, receipt of the measles-mumps-rubella (MMR) vaccine was not associated with an increased risk of autism spectrum disorders (ASD), regardless of whether older siblings had ASD, findings that indicate no harmful association between receipt of MMR vaccine and ASD even among children already at higher risk for ASD, according to a study in the April 21 issue of JAMA, a theme issue on child health.
Although a substantial body of research over the last 15 years has found no link between the MMR vaccine ...
LAST 30 PRESS RELEASES:
[Press-News.org] Mayo Clinic researchers identify methylated DNA markers -- noninvasive cancer screen
